Skip to main content
Equibles
EMBC logo

EMBC · Embecta Corp. · Earnings Call Transcripts & Audio

Track EMBC — free

Use EMBC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EMBC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.66 -0.10 (-1.74%) At close · Sep 30
Russell 2000 member Rebalance outlook locked
Market Cap
$334.29M
Shares
56.66M
Volume · Sep 30 1.42M Avg daily vol (3M) 1.43M

Embecta Corp. Earnings Call Transcripts

Quarterly earnings calls for Embecta Corp. (EMBC), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼8.7% $274.60M −$17.20M '22 Q4 22-12-20 ▼4.7% $275.70M $35.20M '23 Q1 23-02-14 ▲0.9% $277.10M $14.00M '23 Q2 23-05-12 ▼1.7% $286.10M $15.20M '23 Q3 23-08-08 ▲2.7% $281.90M $6.00M '23 Q4 23-11-21 ▲0.6% $277.30M $20.10M '24 Q1 24-02-09 ▲3.6% $287.20M $28.90M '24 Q2 24-05-09 ▼4.8% $272.50M $14.70M '24 Q3 24-08-09 ▲1.5% $286.10M $14.60M '24 Q4 24-11-26 ▼5.6% $261.90M $ '25 Q1 25-02-06 ▼9.8% $259.00M $23.50M '25 Q2 25-05-09 ▲8.4% $295.50M $45.50M '25 Q3 25-08-08 ▼7.7% $264.00M $26.40M '25 Q4 25-11-25 ▼0.3% $261.20M $44.10M '26 Q1 26-02-05 ▼14.4% $221.80M −$4.10M '26 Q2 26-05-05 LATEST ▼8.1% $271.70M $21.10M '26 Q3 26-08-07
Earnings call
FY26 · Q3
2026-08-07
Embecta Corp. (EMBC) Q3 2026 Earnings Call Transcript
Positive tone Owen Mumford acquisition and integration Year-over-year revenue decline Sequential financial improvement
Revenue
$271.70M
▼ 8.1% YoY
Diluted EPS
$0.36
▼ 53.8% YoY
Gross margin
56.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-05-05
Embecta Corp. (EMBC) Q2 2026 Earnings Call Transcript
Cautious tone Q2 revenue shortfall and U.S. business underperformance Owen Mumford acquisition International business and China outlook
Revenue
$221.80M
▼ 14.4% YoY
Diluted EPS
$-0.07
▼ 117.5% YoY
Gross margin
57.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-02-05
Embecta Corp. (EMBC) Q1 2026 Earnings Call Transcript
Positive tone FY2026 guidance and pricing dynamics GLP-1 partnership strategy Strategic roadmap and seed growth phase
Revenue
$261.20M
▼ 0.3% YoY
Diluted EPS
$0.74
Gross margin
61.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-11-25
Embecta Corp. (EMBC) Q4 2025 Earnings Call Transcript
Positive tone Revenue Decline GLP-1 Strategy China Headwinds
Revenue
$264.00M*
▼ 7.7% YoY
Gross margin
60.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-08-08
Embecta Corp. (EMBC) Q3 2025 Earnings Call Transcript
Positive tone Debt reduction and financial flexibility GLP-1 pen-needle opportunity Product portfolio and retail expansion
Revenue
$295.50M
▲ 8.4% YoY
Diluted EPS
$0.78
▲ 212% YoY
Gross margin
66.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-05-09
Embecta Corp. (EMBC) Q2 2025 Earnings Call Transcript
Positive tone Revenue Performance and Guidance Tariffs US Retail Pharmacy Customer / Store Closures
Revenue
$259.00M
▼ 9.8% YoY
Diluted EPS
$0.40
▼ 20% YoY
Gross margin
63.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-02-06
Embecta Corp. (EMBC) Q1 2025 Earnings Call Transcript
Positive tone Revenue decline and tough comps Product portfolio expansion and partnerships FX headwind on guidance
Revenue
$261.90M
▼ 5.6% YoY
Diluted EPS
$0.00
▼ 100% YoY
Gross margin
60.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-11-26
Embecta Corp. (EMBC) Q4 2024 Earnings Call Transcript
Cautious tone Separation from BD Core business and Medicare contracts Patch pump discontinuation
Revenue
$286.10M*
▲ 1.5% YoY
Gross margin
60.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-08-09
Embecta Corp. (EMBC) Q3 2024 Earnings Call Transcript
Positive tone GLP-1 administration and pen needles Separation and ERP implementation Core injection business performance
Revenue
$272.50M
▼ 4.8% YoY
Diluted EPS
$0.25
▼ 3.8% YoY
Gross margin
69.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-05-09
Embecta Corp. (EMBC) Q2 2024 Earnings Call Transcript
Positive tone Revenue growth and Q2 performance Competitive risk: weekly basal insulin / GLP-1s Insulin patch pump program (open- and closed-loop)
Revenue
$287.20M
▲ 3.6% YoY
Diluted EPS
$0.50
▲ 108.3% YoY
Gross margin
64.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-02-09
Embecta Corp. (EMBC) Q1 2024 Earnings Call Transcript
Positive tone Q1 financial results and raised guidance Separation from former parent / standalone infrastructure Insulin patch pump program (Type 2)
Revenue
$277.30M
▲ 0.6% YoY
Diluted EPS
$0.35
▼ 42.6% YoY
Gross margin
67.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-11-21
Embecta Corp. (EMBC) Q4 2023 Earnings Call Transcript
Revenue
$281.90M*
▲ 2.7% YoY
Gross margin
64.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-08-08
Embecta Corp. (EMBC) Q3 2023 Earnings Call Transcript
Revenue
$286.10M
▼ 1.7% YoY
Diluted EPS
$0.26
▼ 75.7% YoY
Gross margin
66.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-05-12
Embecta Corp. (EMBC) Q2 2023 Earnings Call Transcript
Revenue
$277.10M
▲ 0.9% YoY
Diluted EPS
$0.24
▼ 82.6% YoY
Gross margin
68.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-02-14
Embecta Corp. (EMBC) Q1 2023 Earnings Call Transcript
Revenue
$275.70M
▼ 4.7% YoY
Diluted EPS
$0.61
▼ 64.7% YoY
Gross margin
68.5%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-20
Embecta Corp. (EMBC) Q4 2022 Earnings Call Transcript
Revenue
$274.60M*
▼ 8.7% YoY
Gross margin
64.4%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-08-15
Embecta Corp. (EMBC) Q3 2022 Earnings Call Transcript
Revenue
$291.10M
▼ 1.3% YoY
Diluted EPS
$1.07
▼ 40.9% YoY
Gross margin
69.7%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-05-13
Embecta Corp. (EMBC) Q2 2022 Earnings Call Transcript
Revenue
$274.50M
▼ 3.4% YoY
Diluted EPS
$1.38
▼ 26.2% YoY
Gross margin
69.7%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–18 of 18 earnings calls
Key facts CIK 1872789 CUSIP 29082K105 13F (30d) 18 filings 10 filers Visit website Investor relations